Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185249 · ClinicalTrials.gov registry record · NA

Congestive Heart Failure Weight Study

A NA study of Congestive Heart Failure, sponsored by Central DuPage Hospital.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT01185249: Completed NA study of Congestive Heart Failure, sponsored by Central DuPage Hospital.

NCT01185249 is a NA study of Congestive Heart Failure that has completed, run by Central DuPage Hospital. The registered enrollment target is 66 participants, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185249, a NA study of Congestive Heart Failure, has completed, sponsored by Central DuPage Hospital.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

Early morning weights to monitor CHF patient's fluid status is common practice but there is a lack of evidence that this is the best practice. The purpose of this study is to determine if there is a difference in net weight gain or loss for hospitalized patients with CHF who are weighed in the evening instead of early morning.

Conditions Studied

Interventions

  • PROCEDURE Weigh subjects on a scale in the standing position

Study Locations (1)

Illinois

  • Central DuPage Hospital - Winfield

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2009-08
Est. Completion 2011-05
Phase NA
Central DuPage Hospital

3 total trials

What the finished NCT01185249 record still lists

NCT01185249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Weigh subjects on a scale in the standing position is the first listed.

NCT01185249 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01185249 about?

NCT01185249 is a clinical study titled "Congestive Heart Failure Weight Study". Early morning weights to monitor CHF patient's fluid status is common practice but there is a lack of evidence that this is the best practice. The purpose of this study is to determine if there is a difference in net weight gain or loss for hospitalized patients with CHF who are weighed in the eveni...

What is the current status of trial NCT01185249?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2009-08. Estimated completion is 2011-05.

What conditions does trial NCT01185249 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT01185249?

The interventions under investigation include: Weigh subjects on a scale in the standing position (PROCEDURE).

Who is sponsoring clinical trial NCT01185249?

This trial is sponsored by Central DuPage Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01185249 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01185249's enrollment target sits among peer trials

66 32nd of 51 higher than 20 of 51 other Congestive Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01185249, the US trial registry maintained by the National Library of Medicine. NCT01185249 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.